Iron metabolic disorder in chronic hepatitis C: mechanisms and relevance to hepatocarcinogenesis.

作者: Keisuke Hino , Sohji Nishina , Yuichi Hara

DOI: 10.1111/JGH.12243

关键词:

摘要: The liver is the major iron storage organ in body, and therefore, metabolic disorder sometimes involved chronic diseases. Chronic hepatitis C one of diseases that show hepatic accumulation, even though its level should be recognized to basically mild moderate within normal range. mechanisms underlying accumulation have not been fully elucidated. Reduction hepcidin transcription activity by virus (HCV)-induced reactive oxygen species may part account for it, but regulation very complex depend on many variables, including particular stage systemic and/or inflammatory conditions circulating transferrin-bound intracellular stores. This might explain variations concentrations reported among patients with HCV-related disease. However, mild-to-moderate overload contributes disease progression hepatocarcinogenesis probably reinforcing HCV-induced oxidative stress through Fenton reaction. present review highlights current concept status discusses how develops this impact relevance hepatocarcinogenesis.

参考文章(52)
Naoki Fujita, Ryosuke Sugimoto, Masaki Takeo, Naohito Urawa, Rumi Mifuji, Hideaki Tanaka, Yoshinao Kobayashi, Motoh Iwasa, Shozo Watanabe, Yukihiko Adachi, Masahiko Kaito, Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Molecular Medicine. ,vol. 13, pp. 97- 104 ,(2007) , 10.2119/2006-00057.FUJITA
David Brandhagen, Lorenzo Rossaro, Christopher L. Bowlus, Mary F. Burritt, Christopher A. Aoki, Rajendra Ramsamooj, Liver hepcidin mRNA correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. Journal of Clinical Gastroenterology. ,vol. 39, pp. 71- 74 ,(2005)
Matthias W Hentze, Martina U Muckenthaler, Nancy C Andrews, Balancing Acts: Molecular Control of Mammalian Iron Metabolism Cell. ,vol. 117, pp. 285- 297 ,(2004) , 10.1016/S0092-8674(04)00343-5
Tracey A. Rouault, Victor Gordeuk, Gregory Anderson, The Central Role of the Liver in Iron Storage and Regulation of Systemic Iron Homeostasis Liver. pp. 215- 228 ,(2020) , 10.1002/9780470747919.CH16
Adriana Donovan, Alison Brownlie, YI Zhou, Jennifer Shepard, Stephen J Pratt, John Moynihan, Barry H Paw, Anna Drejer, Bruce Barut, Agustin Zapata, Terence C Law, Carlo Brugnara, Samuel E Lux, Geraldine S Pinkus, Jack L Pinkus, Paul D Kingsley, James Palis, Mark D Fleming, Nancy C Andrews, Leonard I Zon, None, Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter Nature. ,vol. 403, pp. 776- 781 ,(2000) , 10.1038/35001596
Alexander Krause, Susanne Neitz, Hans-Jürgen Mägert, Axel Schulz, Wolf-Georg Forssmann, Peter Schulz-Knappe, Knut Adermann, LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity FEBS Letters. ,vol. 480, pp. 147- 150 ,(2000) , 10.1016/S0014-5793(00)01920-7
Sohji Nishina, Keisuke Hino, Masaaki Korenaga, Chiara Vecchi, Antonello Pietrangelo, Yoichi Mizukami, Takakazu Furutani, Aya Sakai, Michiari Okuda, Isao Hidaka, Kiwamu Okita, Isao Sakaida, Hepatitis C Virus–Induced Reactive Oxygen Species Raise Hepatic Iron Level in Mice by Reducing Hepcidin Transcription Gastroenterology. ,vol. 134, pp. 226- 238 ,(2008) , 10.1053/J.GASTRO.2007.10.011
Domenico Girelli, Michela Pasino, Julia B. Goodnough, Elizabeta Nemeth, Maria Guido, Annalisa Castagna, Fabiana Busti, Natascia Campostrini, Nicola Martinelli, Italo Vantini, Roberto Corrocher, Tomas Ganz, Giovanna Fattovich, Reduced serum hepcidin levels in patients with chronic hepatitis C Journal of Hepatology. ,vol. 51, pp. 845- 852 ,(2009) , 10.1016/J.JHEP.2009.06.027
Elizabeta Nemeth, Marie S Tuttle, Julie Powelson, Michael B Vaughn, Adriana Donovan, Diane McVey Ward, Tomas Ganz, Jerry Kaplan, Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization Science. ,vol. 306, pp. 2090- 2093 ,(2004) , 10.1126/SCIENCE.1104742